You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

 

Online download statistics by month:

Online download statistics by month: October 2021 to February 2026

AbstractFullPdf
Oct 2021013417
Nov 202107514
Dec 20210487
Jan 20220319
Feb 202202213
Mar 20220217
Apr 20220269
May 202202910
Jun 20220245
Jul 20220204
Aug 20220223
Sep 202202212
Oct 202201811
Nov 20220104
Dec 20220125
Jan 202301313
Feb 20230314
Mar 2023062
Apr 2023035
May 2023053
Jun 2023094
Jul 2023067
Aug 20230510
Sep 2023039
Oct 20230117
Nov 20230110
Dec 20230195
Jan 20240113
Feb 20240187
Mar 20240525
Apr 20240611
May 2024030
Jun 20240133
Jul 20240257
Aug 2024095
Sep 20240179
Oct 20240105
Nov 20240227
Dec 20240133
Jan 20250123
Feb 2025061
Mar 20250173
Apr 20250252
May 20250123
Jun 20250163
Jul 2025010
Sep 2025060
Feb 2026010
Total0884299